1. Home
  2. ADM vs IQV Comparison

ADM vs IQV Comparison

Compare ADM & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer-Daniels-Midland Company

ADM

Archer-Daniels-Midland Company

HOLD

Current Price

$71.41

Market Cap

30.4B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$171.85

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADM
IQV
Founded
1902
1982
Country
United States
United States
Employees
N/A
93000
Industry
Packaged Foods
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4B
28.6B
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
ADM
IQV
Price
$71.41
$171.85
Analyst Decision
Hold
Strong Buy
Analyst Count
6
16
Target Price
$64.00
$230.56
AVG Volume (30 Days)
3.6M
1.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
2.88%
N/A
EPS Growth
N/A
4.67
EPS
2.23
7.84
Revenue
$80,269,000,000.00
$9,739,000,000.00
Revenue This Year
$5.04
$6.77
Revenue Next Year
$2.74
$5.87
P/E Ratio
$32.35
$21.79
Revenue Growth
N/A
41.60
52 Week Low
$43.19
$134.65
52 Week High
$74.19
$247.05

Technical Indicators

Market Signals
Indicator
ADM
IQV
Relative Strength Index (RSI) 53.53 50.68
Support Level $57.63 $159.42
Resistance Level $73.96 $193.26
Average True Range (ATR) 2.44 6.17
MACD 0.01 1.66
Stochastic Oscillator 72.15 63.81

Price Performance

Historical Comparison
ADM
IQV

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: